EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Usefulness of C. elegans Models of Alzheimer’s and Huntington’s Disease to Evaluate Novel Imidazoline I2 Receptor Ligands

Teresa Taboada-Jara iD, Marta Ribalta, Fernando Romero-Becerra, Joel Muixí, Aina Bellver-Sanchis, Christian Griñán-Ferré iD, Carmen Escolano iD, Mercè Pallàs iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27073282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Teresa Taboada-Jara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Section, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociè…. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Huntington Disease, Imidazoline Receptors, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Agència de Gestió d'Ajuts Universitaris i de Recerca, Ministerio de Economía y Finanzas and Programa Nacional de Becas "Don Carlos Antonio López".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases such as Alzheimer’s (AD) and Huntington’s (HD) remain major therapeutic challenges due to limited treatment efficacy. Imidazoline I2 receptor (I2-IR) ligands have recently emerged as promising neuroprotective agents, with reported roles in modulating oxidative stress, neuroinflammation, and protein aggregation. This study evaluates the therapeutic potential of several I2-IR ligands, including Idazoxan, CR4056, and novel compounds, using Caenorhabditis elegans (C. elegans) models of AD and HD. Transgenic strains CL2006 (expressing human Aβ1-42) and EAK103 (expressing Ht513) were employed to assess locomotor activity, oxidative stress tolerance, Aβ and Ht aggregation, and sod-1 gene expression. Several ligands significantly improved movement, reduced Aβ and Ht aggregates, and enhanced antioxidant gene expression, particularly Idazoxan, LSL42, and PIP01. Notably, some compounds exhibited prooxidant effects, highlighting the utility of C. elegans for early in vivo toxicity screening. Importantly, this study provides the first in vivo evidence of the efficacy of I2-IR ligands in HD models and reinforces their potential as therapeutic candidates for HD. Overall, these findings suggest a potential role for modulation of I2-IR-related pathways in neurodegeneration and support the utility of C. elegans as a rapid, cost-effective platform for preclinical drug evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansHuntington DiseaseImidazoline ReceptorsAlzheimer DiseaseNeuroprotective AgentsAnimalsDisease Models, AnimalLigandsOxidative StressHumansAmyloid beta-PeptidesAnimals, Genetically ModifiedCaenorhabditis elegans Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseAβ aggregationC. elegans modelsHt513 aggregatesHuntington’s diseaseimidazoline I2 receptor ligandsneurodegenerationoxidative stresssod-1 gene expression

Substanzen

Imidazoline ReceptorsLigandsAmyloid beta-Peptidesimidazoline receptor 2Neuroprotective AgentsCaenorhabditis elegans Proteins

Autor:innen und Institutionen

  • Pharmacology Section, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències (UBNeuro), University of Barcelona, 08028 Barcelona, Spain.
  • Laboratory of Medicinal Chemistry, Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
  • Institute of Biomedicine (IBUB), University of Barcelona, 08028 Barcelona, Spain.
  • CiberNed-Network Center for Neurodegenerative Diseases, National Spanish Health Institute Carlos III, 28220 Madrid, Spain.

ORCID-Profile: Teresa Taboada-Jara, Christian Griñán-Ferré, Carmen Escolano, Mercè Pallàs

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Ministerio de Economía y Finanzas and Programa Nacional de Becas "Don Carlos Antonio López"
  • Càtedra UB Dr. Antoni Esteve i Subirana de Recerca en Farmacologia
  • Ministerio de Economía y Finanzas and Programa Nacional de Becas “Don Carlos Antonio López”

Zitieren

APA

Taboada-Jara, T., Ribalta, M., Romero-Becerra, F., Muixí, J., Bellver-Sanchis, A., Griñán-Ferré, C., Escolano, C., & Pallàs, M. (2026). Usefulness of C. elegans Models of Alzheimer’s and Huntington’s Disease to Evaluate Novel Imidazoline I2 Receptor Ligands. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27073282

Vancouver

Taboada-Jara T, Ribalta M, Romero-Becerra F, Muixí J, Bellver-Sanchis A, Griñán-Ferré C, et al. Usefulness of C. elegans Models of Alzheimer’s and Huntington’s Disease to Evaluate Novel Imidazoline I2 Receptor Ligands. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27073282

BibTeX
@article{TaboadaJara2026,
  author = {Taboada-Jara, Teresa and Ribalta, Marta and Romero-Becerra, Fernando and Muixí, Joel and Bellver-Sanchis, Aina and Griñán-Ferré, Christian and Escolano, Carmen and Pallàs, Mercè},
  title = {Usefulness of C. elegans Models of Alzheimer’s and Huntington’s Disease to Evaluate Novel Imidazoline I2 Receptor Ligands},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27073282}
}
Kostenlos starten →